Fig. 9.1
Incidence of dissection of the aorta in Marfan syndrome. Marfan syndrome patients tend to experience dissection of the aorta during pregnancy than nonpregnant period (4.4 % vs. 0.9 %, p < 0.05)
Table 9.1.
Aortic dissection/dilatation and Marfan syndrome complicated pregnancy
Number of pregnancy | Cardiac events (Dilatation/dissection) (%) | Report | Country |
---|---|---|---|
105 | 0 | 1981 Pyeritz | USA |
45 | 2 (4.4) | 1995 Rositter | USA |
91 | 6 (6.6) | 1997 Lipscomb | UK |
117 | 5 (4.3) | 2001 Lind | Holland |
160 | 7 (4.4) | 2009 Pacinni | France |
29 | 9 (31) | 2013 Katsuragi | Japan |
547 | 29 (5.3) |
Fig. 9.2
Change of the diameter of the Valsalva of 21 Marfan syndrome patients. Aortic event occurred when Ao ≥ 40 mm
The basic aortic risks in pregnancy are an aortic diameter ≥4.0 cm [7–10, 12–14] and a steady increase in the aortic root dimension during pregnancy [9, 10, 12, 15]. Meijboom et al. reported that pregnancy in women with Marfan syndrome seems to be relatively safe up to an aortic root diameter of 45 mm [16]. However, most previous reports on Marfan syndrome in pregnancy have been from North America or Europe, and people in these areas have relatively larger number of physiques, or different physiques of patients might have been intermingled. Since normal aortic dimensions vary with age and body size [17], the same aortic dimension represents a proportionally greater diameter in smaller individuals, and proper interpretation of the aortic dimension requires that age and body size are accounted for. Therefore, the absolute aortic size cannot be directly used to evaluate risk in patients with a small physique [18], such as Japanese women.
The risk factors for aortic complications in pregnant patients affected with Marfan syndrome have not been examined with inclusion of a consideration of the body surface area. Therefore, to permit appropriate consultation and management of patients, we studied 29 consecutive pregnant patients with Marfan syndrome in one institution to determine the factors that influence maternal aortic complications.
9.1.3 Monitoring for Dilatation and Dissection of the Aorta in Marfan Syndrome Patients During Pregnancy
9.1.3.1 Measurement of the Aortic Diameter and Indication for Surgery
Diameter of the sinus of Valsalva can be measured by echocardiography during pregnancy [17, 19]. MRI can be used during pregnancy, but CT is not usually examined due to radiation exposure. The Japanese Circulation Society recommends an operation for Marfan patients with a sinus of Valsalva over 5 cm [20]. Some surgeons also prefer an operation for patients with a sinus of Valsalva over 4.5 cm [21]. In our institution, surgical intervention is indicated according to the above criteria especially patients with a family history of dissection or sudden death. In general, surgical intervention is indicated for a sinus of Valsalva over 4.0 cm or in a case with steady aortic size growth [22, 23]. During pregnancy, surgical intervention is indicated if there is progressive aortic growth with a sinus of Valsalva of 4.0 cm (4.5 cm) or massive dissection. To standardize the measurement based on body size, the size of the sinus of Valsalva could be evaluated using the aortic size index (ASI), which is calculated as ASI = aortic diameter (mm)/body surface area (m2) [18].
9.1.3.2 Cardiovascular Events Monitoring During Pregnancy
Echocardiographic follow-up including aortic diameter measurement and Holter electrocardiogram could be necessary at least once in each trimester during pregnancy and within 4 weeks after delivery. If the aortic root diameter is over ≥40 mm, echocardiography could be performed every 2 weeks in the second and the third trimester. Marfan syndrome is occasionally complicated with mitral valve prolapse and regurgitation. Regurgitation may be worsening from mild to severe during pregnancy, and it will develop arrhythmias. In these cases, Holter electrocardiogram is useful to decide whether it is better to introduce antiarrhythmic medication such as beta-blockade.
When surgical intervention is indicated, the operation should be performed after cesarean section when a fetus is already matured. But if the fetus is immature to live independently, the aortic operation could be performed with the fetus in the uterus.
9.1.4 Aortic Risks in Marfan Syndrome Patients During Pregnancy
9.1.4.1 Case Series of Aortic Dilatation or Dissection [12 ]
Eleven of 29 cases with Marfan women had aortic dilatation or dissection associated with pregnancy, including 7 that occurred during pregnancy and 4 within 1 year after pregnancy (group D). One case underwent hemiarch replacement and one underwent a David operation during pregnancy. Three underwent Bentall operations following delivery by cesarean section, and two received conservative therapy after cesarean section. The incidence of cesarean section was higher in patients with aortic dilatation/dissection. A family history of sudden death or aortic dissection was more frequent in patients with aortic dilatation/dissection.
9.1.4.2 Echocardiographic Data in Cases With and Without Aortic Dilatation or Dissection
By echocardiography, a sinus of Valsalva ≥40 mm in the first trimester was more frequent in patients with aortic dilatation/dissection (Fig. 9.3).
Fig. 9.3
Diameters of the sinus of Valsalva. D/D indicates aortic dilatation or dissection. Cases with and without aortic dilatation or dissection are shown by red and blue circles, respectively (group D and group ND, respectively). Pink squares indicate a cardiac event. In the first trimester, a larger sinus of Valsalva was found in group D compared to group ND (41.5±2.4 vs. 34.8±1.3, P < 0.05 by student t-test). The sinus of Valsalva was ≥40 mm in 6/7 cases in group D and 3/14 in group ND (P < 0.05 by chi-square test and Fisher exact test)
An aortic size index (ASI) (diameter of the sinus of Valsalva/body surface area) ≥25 mm/m2 was more frequent in n patients with aortic dilatation/dissection (Fig. 9.4). Significantly faster growth of the sinus of Valsalva was also observed in patients with aortic dilatation/dissection (Fig. 9.5).
Fig. 9.4
Adjusted sizes of the sinus of Valsalva (size of the sinus of Valsalva/body surface area, mm/m2). D/D indicates aortic dilatation or dissection. Cases with and without aortic dilatation or dissection are shown by red and blue circles, respectively (group D and group ND, respectively). In the first trimester, the adjusted size of the sinus of Valsalva was ≥25 mm/m2 in 7/7 cases in group D and 0/14 in group ND (P < 0.0001 by chi-square test and Fisher exact test)
Fig. 9.5
Rate of growth of the sinus of Valsalva. Significantly faster growth of the sinus of Valsalva was observed in group D (red box) than in group ND (blue box). The middle bar indicates the 50th percentile; box edges are the 25th and 75th percentiles; and outer bars are the 10th and 90th percentiles. Data were analyzed by Wilcoxon test. *P < 0.05
In the first trimester of pregnancy, patients with aortic dilatation/dissection showed more frequent moderate to severe aortic and mitral valve regurgitation.
9.1.5 Risk Factors for Aortic Dilatation/Dissection
The risk factors that differed significantly between groups D and ND were mostly consistent with those found in previous studies [7–10, 14]. The risk factors for pregnancy-associated dilatation or dissection are a large sinus of Valsalva, rapid growth of the sinus of Valsalva during pregnancy, moderate to severe aortic valve or mitral valve regurgitation, and family history of sudden death or aortic dissection [7–10, 15].
According to the relatively large prospective study of Meijboom et al. [16], pregnancy in women with Marfan syndrome seems to be relatively safe up to an aortic root diameter of 45 mm. Also, Canadian guidelines [23] recommend that women with an aortic root diameter beyond 44 mm should be strongly discouraged from becoming pregnant. In a case report of a patient who developed a massive retrograde type B aortic dissection 7 days after normal spontaneous vaginal delivery, Gandhi et al. [24] described the patient as “petite” (body surface area, 1.69 m2); however, in case of smaller physics such as Asian and Japanese woman, the cutoff value for regarding avoidance of pregnancy may be a sinus of Valsalva diameter ≥40 mm, rather than ≥45 mm.
9.1.6 Adjusted Aortic Size Index Is Applicable for Small Physics
The diameter of the sinus of Valsalva adjusted for body surface area (diameter of the Valsalva/body surface area, mm/m2) may be more appropriate for selection of high-risk cases before pregnancy. The relative aortic size was first used to predict complications in patients with thoracic aortic aneurysms [18]. An aortic size index (ASI) ≥25 mm/m2 in the first trimester is possibly a risk factor for aortic dilatation or dissection during pregnancy and postpartum. The ASI is a novel measurement of relative aortic size that predicts rupture of aortic aneurysm [18], and Davies et al. found that the ASI was more important than absolute aortic size in predicting aortic complications, especially in smaller women [18]. There was more rapid growth of the sinus of Valsalva in patients with Marfan syndrome with pregnancy-associated aortic dilatation or dissection, compared to those without these conditions. Therefore, even if the diameter of the sinus of the Valsalva is small, rapid growth carries a risk of aortic dissection or dilatation. The same phenomenon has been reported in nonpregnant cases of Marfan syndrome. Meijboom et al. [25] followed 108 women with Marfan syndrome and aortic root growth prospectively using serial echocardiograms and found that the patients could be divided into two normally distributed groups based on aortic growth rates: 90 % were slow growers and 10 % were fast growers. Higher incidence of dissections of the ascending aorta (25 % vs. 4 %, P < 0.001) is observed in the fast growers, and the average growth of the sinus of Valsalva in the fast group was 1.8 mm/year. The median growth in the five dissected cases was as high as 4.1 mm/year [12 ]. This larger increase relative to that in Meijboom et al. [16] is probably due to the influence of hemodynamic change including increased blood volume, heart rate, and stroke volume during pregnancy. Furthermore, hormonally mediated histological changes also occur in the aorta, including a decrease in mucopolysaccharides and loss of elastic fibers in the aortic wall [26–28]. Therefore, care is required in treating patients with a high growth rate of the sinus of Valsalva. The frequency and degree of aortic and mitral valve regurgitation were also higher in cases with aortic dilatation or dissection, and these valvular changes may have positive impact on dilatation or dissection.